Lilly rides Mounjaro, Zepbound to better
Release time：2024-05-22 01:55:26 Source：Global Glimmer news portal
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
- Previous：Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
- Next：Judge orders man accused of opening fire outside Wrigley Field held without bail
Related articles
- Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
- China's Qinghai sees significant growth in green coverage in 2023
- China's top court vows better judicial protection of consumer rights
- Hamas says UNSC resolution demanding Gaza truce shows Israel's isolation
- ‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
- Researchers uncover future variations of irrigation water use in China
- Eurozone inflation further cools in March
- China sees steady progress in diagnosis, treatment system: health official
- ‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
- Chinese heritage attracts Universiade athletes in Chengdu
- Messi in and Dybala out in Argentina squad for pre
- Hong Kong defends new security law
- DPP obstruction to mainland products unpopular: Spokesperson
- Hamas says UNSC resolution demanding Gaza truce shows Israel's isolation
- Rays opening day starter Zach Eflin placed on 15
- Hamas says UNSC resolution demanding Gaza truce shows Israel's isolation
- Eurozone inflation further cools in March
- China's Qinghai sees significant growth in green coverage in 2023
- Amal Clooney played key role in ICC bid to request arrest warrants for Israeli PM and Hamas leader
- Türkiye's opposition takes election lead in key cities
Random recommendation
- Copyright © 2024 Powered by Lilly rides Mounjaro, Zepbound to better ,Global Glimmer news portal sitemap